tiprankstipranks
Advertisement

PAWZ - ETF AI Analysis

Compare

Top Page

PAWZ

ProShares Pet Care ETF (PAWZ)

Rating:67Neutral
Price Target:
PAWZ, the ProShares Pet Care ETF, earns a solid overall rating driven by high-quality leaders like Idexx Laboratories and Zoetis, which bring strong financial performance, positive trends, and shareholder-friendly actions such as dividends and buybacks. Additional support comes from companies like Virbac and Nestlé, which add stability through robust revenue and profitability, while some holdings such as Chewy and Pet Valu face technical weakness, valuation concerns, or leverage that slightly weigh on the fund. The main risk factor is the fund’s focus on the pet care industry, which concentrates exposure in a single theme and can amplify the impact of sector-specific challenges.
Positive Factors
Global Pet Care Focus
The fund targets companies tied to the growing pet care industry across several countries, giving investors focused exposure to this long-term theme.
International Diversification
Holdings spread across the U.S., Europe, Canada, Japan, and Switzerland help reduce the impact of weakness in any single country.
Balanced Sector Mix
Exposure to health care, consumer cyclical, and consumer defensive sectors provides a mix of growth potential and more stable, defensive businesses.
Negative Factors
Weak Recent Performance
The ETF’s returns over the year to date and recent three-month period have been negative, signaling recent performance challenges.
Top Holdings Under Pressure
Several of the largest positions, including some major pet-focused companies, have shown weak performance so far this year, which can drag on the fund.
High Expense Ratio
The fund’s expense ratio is relatively high for an ETF, which means more of the returns are eaten up by fees over time.

PAWZ vs. SPDR S&P 500 ETF (SPY)

PAWZ Summary

The ProShares Pet Care ETF (PAWZ) follows the FactSet Pet Care Index and focuses on companies that make money from pets and pet owners. It holds businesses involved in pet food, vet care, pet insurance, and pet products, including well-known names like Chewy and Nestlé. Someone might invest in this ETF to tap into the long-term growth of the global pet industry while spreading their money across many pet-related companies instead of picking just one stock. A key risk is that it is heavily focused on the pet care sector, so it can rise or fall more than the overall market if this niche goes out of favor.
How much will it cost me?The ProShares Pet Care ETF (PAWZ) has an expense ratio of 0.50%, meaning you’ll pay $5 per year for every $1,000 invested. This is higher than average for ETFs because it is actively managed and focuses on a niche sector, which typically requires more specialized research and management.
What would affect this ETF?The ProShares Pet Care ETF could benefit from rising global pet ownership and increased spending on pet health and wellness, as pets are increasingly treated as family members. However, economic downturns or higher interest rates could negatively impact consumer spending on non-essential pet products and services, and regulatory changes in the healthcare sector might affect key holdings like Idexx Laboratories and Zoetis. The ETF’s global exposure also makes it sensitive to international market conditions and currency fluctuations.

PAWZ Top 10 Holdings

PAWZ is a pure play on the global pet boom, but its leaders are pulling in different directions. Chewy has perked up recently yet remains weighed down by earlier stumbles, while Idexx Laboratories and Zoetis have been lagging, keeping a lid on gains from the veterinary side. Freshpet is one of the brighter spots, with rising momentum, and France’s Virbac is quietly helping steady the ship. With a heavy tilt toward health care and consumer pet brands across the U.S., Europe, and Canada, the fund is concentrated in a single theme but diversified by geography.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Chewy10.02%$4.07M$10.69B-28.81%
54
Neutral
Freshpet9.98%$4.06M$3.22B-12.73%
66
Neutral
Idexx Laboratories9.82%$4.00M$44.55B27.20%
78
Outperform
Zoetis9.71%$3.95M$48.81B-23.80%
74
Outperform
Virbac SA7.75%$3.15M€3.17B22.91%
75
Outperform
Trupanion4.80%$1.95M$1.17B-26.95%
69
Neutral
Pet Valu Holdings Ltd.4.62%$1.88MC$1.47B-20.98%
65
Neutral
CVS Group plc4.54%$1.85M£842.58M18.21%
66
Neutral
Nestlé SA4.50%$1.83MCHF202.31B-5.12%
71
Outperform
Pets at Home4.45%$1.81M£832.04M-18.88%
74
Outperform

PAWZ Technical Analysis

Technical Analysis Sentiment
Negative
Last Price
Price Trends
50DMA
53.35
Negative
100DMA
54.26
Negative
200DMA
55.06
Negative
Market Momentum
MACD
0.12
Negative
RSI
48.43
Neutral
STOCH
24.79
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For PAWZ, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 52.41, equal to the 50-day MA of 53.35, and equal to the 200-day MA of 55.06, indicating a neutral trend. The MACD of 0.12 indicates Negative momentum. The RSI at 48.43 is Neutral, neither overbought nor oversold. The STOCH value of 24.79 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for PAWZ.

PAWZ Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$41.10M0.50%
67
Neutral
$98.78M0.75%
72
Outperform
$98.19M1.00%
69
Neutral
$97.72M0.50%
59
Neutral
$32.52M0.69%
75
Outperform
$3.61M0.58%
57
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
PAWZ
ProShares Pet Care ETF
52.60
0.37
0.71%
YNOT
Horizon Digital Frontier ETF
FFND
Future Fund Active ETF
CSNR
Cohen & Steers Natural Resources Active ETF
LOGO
Tidal Trust III Alpha Brands Consumption Leaders ETF
OND
ProShares On-Demand ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement